Home Tags Clinical Trials

Tag: Clinical Trials

Cofactor Genomics and Culmination Bio are Partners to Utilize the U.S. Largest Biobank for PREDAPT Precision Medicine Clinical Trial

Culmination Bio Partners with Cofactor Genomics to Utilize the U.S. Largest Biobank for PREDAPT...

Culmination Bio, a recently established Intermountain Health Company, and Cofactor Genomics, a company specializing in predictive diagnostic immunotherapy, recently announced a strategic partnership. The aim of this collaboration is to utilize samples and data from one of the nation's...
DARWIN EU® Welcomes European Medicines Agency (EMA) Selected First Data Partners to Generate Real-World Evidence

DARWIN EU® Welcomes European Medicines Agency (EMA) Selected First Data Partners to Generate Real-World...

EMA has selected the first set of data partners to collaborate with DARWIN EU®, the Data Analysis and Real-World Interrogation Network. The data available to these partners will be used for studies to generate real-world evidence that will support scientific evaluations and regulatory decision making....
New Biobank to Boost Research in the Field of Pediatric and Young People’s Cancers

New Biobank in UK Created to Advance Research on Pediatric and Young People’s Cancers

VIVO Biobank is supported by the charities Cancer Research UK and Blood Cancer UK and will provide cancer researchers with a centralised collection of cell and tissue samples from children and young people affected by cancer across the country. The samples...
Texas Heart Institute Biorepository Received Equipment Grant from NIH to Support Automation and Modernization

Texas Heart Institute Biorepository Received Equipment Grant from NIH to Support Automation and Modernization

The Texas Heart Institute (THI) Biorepository and Biospecimen Profiling Core Laboratory has received an R24 grant award from the National Institutes of Health (NIH) to support the automation and modernization of the facility’s sample storage and handling process. With this $220,000...
Biobank and Pharma Services now have Commercial Access to Lifespin's Metabolic Profiler Software and Database

Biobank and Pharma Services now have Commercial Access to Lifespin’s Metabolic Profiler Software and...

Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced that it has launched a new commercial service for the pharmaceutical and biobanking industry to assist companies in key phases of research, development, and manufacturing. Immediate applications of...
UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services

UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services

UK Biocentre has been granted ISO 15189:2012 Accreditation by UKAS for sample processing and storage services. This landmark accreditation further extends UK Biocentre’s capabilities, increasing the scope of services it can provide to support clinical trials and studies, including...

Grünenthal And Mesoblast Partner To Develop Allogeneic Cell Therapy For Chronic Low Back Pain

Grünenthal, a global leader in pain management, and Mesoblast Limited, a world leader in allogeneic cellular medicines for inflammatory diseases, have entered into a strategic partnership to develop and commercialise MPC-06-ID, a Phase III allogeneic cell therapy candidate for the treatment of chronic...

Mission Bio And Onconova Partner To Use Tapestri® Platform Single-Cell DNA Analysis In Clinical...

Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, and Onconova Therapeutics, have formed a collaboration to utilize the Mission Bio Tapestri® Platform for targeted single-cell DNA analysis to study Onconova’s novel cancer therapy, rigosertib, through clinical trials. Founded in 2012,...

Meeting – C-Path and NORD Launch The Rare Disease Cures Accelerator-Data and Analytics Platform

The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, Maryland, to formally launch development of a new rare disease data and analytics platform. Funded by...

Gamida Cell Presented Omidubicel Cell Therapy For Blood Cancers At ISCT Meeting In Melbourne

Two presentations on omidubicel (formerly known as NiCord®), an investigational advanced cell therapy in Phase 3 clinical development designed to enhance the life-saving benefits of hematopoietic stem cell (bone marrow) transplant, developed by Gamida Cell Ltd., a leading cellular and immune therapeutics company,...

⭐ Recently Featured

🔥 Popular Posts

X